Point72 Hong Kong LTD Dexcom Inc Put Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $145,065 - $178,942	1,900 Added 19.0%	11,900 $958,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $135,980 - $265,780	2,000 Added 25.0%	10,000 $745,000
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $498,624 - $690,059	5,300 Added 196.3%	8,000 $4.09 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $181,818 - $227,948	-1,400 Reduced 34.15%	2,700 $1.45 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $480,195 - $644,310	-4,500 Reduced 52.33%	4,100 $2.24 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $534,534 - $712,338	6,600 Added 330.0%	8,600 $3.67 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $93,269 - $115,214	1,100 Added 122.22%	2,000 $719,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $70,200 - $94,050	900 New	900 $333,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.